APPLICATIONS PUBLISHED 16 FEBRUARY 2005
Published: 1-Mar-2006
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Methods of treating allergic reactions
Collagenex Pharmaceuticals 1505961*
Monotherapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX 2) inhibitor(s)
Pharmacia 1505962*
Hepatitis C virus inhibitors
Bristol-Myers Squibb 1505963*
Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
Merckle 1505964*
Use of valsartan otitis metabolite to inhibit platelet aggregation
Novartis 150965*
1,1-disubstituted cycloalkyl derivatives as factor XA inhibitors
Bristol-Myers Squibb 1505966*
Method for treating obesity
Duke University 1505967*
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
Eli Lilly 1505968*
Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
Bristol-Myers Squibb Pharma Company 1505969*
Methods of using thiazolidine derivatives to treat cancer or inflammation
QLT 1505970*
Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
Nastech Pharmaceutical Company 1505972*
A selective INOS inhibitor and a PDE inhibitor in combination for the treatment of respiratory diseases
Pharmacia 1505973*
Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
Celgene 1505974*
Use of compounds that are effective as selective opiate receptor modulators
Merck Patent 1505974*
Synergistic combination of an opioid analgesic and a NSAID
Akzo Nobel 1505976*
Administration of a partial fatty acid inhibitor such as ranolazine
CV Therapeutics 1505977*
Polymorphic forms of phenyl oxazolidinone derivatives
Ranbaxy Laboratories 1505978*
Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
Merck 1505979*
Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
Tibotec Pharmaceuticals 1505980*
Utilisation of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy
Boehringer Ingelheim Pharma 1505981*
Trimegestone and estrogens for treating post menopausal disorders
Wyeth 1505982*
Aldosterone blocker therapy to prevent or treat inflammation-related disorders
Pharmacia 1505983*
Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
The Quigley Corporation 1505984*
Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events
Merck 1505985*
Combination of an HMG-CoA reductase inhibitor and a nitrate ester
Scaramuzzino, Giovanni 1505986*
Stable amorphous celecoxib composite and process therefor
Pharmacia 1505987*
Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions
Imaginative Research Associates 1505988*
Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
Cedars-Sinai Medical Centre 1505989*
Methods of treating hepatitis
Yale University; University of Pittsburgh of the Commonwealth System of Higher Education 1505990*
A drugs association against influenza virus
Zambion Group 1505991*
Method for reducing pain using oncolytic viruses
Oncolytics Biotech 1505992*
Sensitisation of neoplastic cells to radiation therapy with oncolytic viruses
Oncolytics Biotech 1505993*
Novel use of the extract of processed ginseng and saponin isolated therefrom
Hongrim Trading Co. 1505994*
Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target
Purdue Research Foundation 1505999*
Heterocyclicsulfonamide hepatitis C virus inhibitors
Bristol-Myers Squibb 1506000*
Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
The General Hospital Corp 1506001*
Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
Protein Design Labs 1506002*
Soluble formulations comprising insulin aspart and insulin detemir
Novo Nordisk 1506003*
Means for use in treating diseases correlated with or caused by nonphysiological levels of microtubule- associated PP2AC
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1506004*
Methods for the in vitro culture of Sporozoea sp. and user thereof
Schering-Plough 1506005*
Improved combined vaccine against mycoplasma hypopneumoniae and porcine viruses
Wyeth 1506006*
Mucosal combination vaccines for bacterial meningitis
Chiron SRL 1506007*
Mucosal vaccines with chitosan adjuvant and/or meningococcal antigens
Universiteit Leiden, Leiden/Amsterdam Centre for Drug Research 1506008*
Glucan-based vaccines
Polonelli, Luciano; Cassone, Antonio 1506009*
Methylated immunostimulatory oligonucleotides and methods of using the same
Inex Pharmaceuticals 1506010*
An antibody selective for a tumour necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
UAB Research Foundation 1506011*
Use of a vaccine for active immunisation against cancer
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-AC 1506012*
Chimeric allograft tolerance induction, monitoring and maintenance
The Cleveland Clinic Foundation 1506013*
Process for the preparation and activation of substances and a means of producing same
Chemstop 1506014*
Pharmaceutical combination of PDE5 inhibitors with ACE inhibitors
Pfizer 1506015*
New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
Altana Pharma 1506016*
Personal nutrition control method
Gordon, Roni 1506017*
Druh pre-targeting by means of bispecific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
Immunomedics 1506018*
Complexes for the delivery of biologically-active material to cells
University College London 1506019*
Process for inhibiting gene expression using polynucleotides
Mirus Corp 1506020*
Novel use of adenoviruses and nucleic acids coding therefor
Holm, Per Sonne 1506021*
Selective INOS inhibitors for the treatment of respiratory diseases and conditions
Pharmacia 1506040*
Bisphosphonic acids for the treatment and prevention of osteoporosis
F Hoffmann-La Roche 1506041*
